﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>17</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2014</Year>
        <Month>04</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Detection and Biological Characteristic of FLT3 Gene Mutations in Children with Acute Leukemia</ArticleTitle>
    <FirstPage>0</FirstPage>
    <LastPage>0</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nahid</FirstName>
        <LastName>Nasiri</LastName>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Shaikhy</LastName>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Zaker</LastName>
      </Author>
      <Author>
        <FirstName>Soudabeh</FirstName>
        <LastName>Hosseini</LastName>
      </Author>
      <Author>
        <FirstName>S. A.</FirstName>
        <LastName>Moosavi</LastName>
      </Author>
      <Author>
        <FirstName>Abdol Jalal</FirstName>
        <LastName>Marjani</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>INTRODUCTION: FLT3 ITD and D835 mutations occur in high frequency in AML and to a lower rate in ALL patients with poor prognosis.  METHODS: ITD and D835 mutations were studied in 100 diagnosed acute leukemia patients including 27 AML and 73 ALL with various FAB classifications by PCR and PCR-RFLP, respectively. Subsequently, PCR products of positive samples were confirmed by sequencing analyses. RESULTS: ITD mutations occurred in 10% of all pediatric acute leukemia, including AML and ALL. 25.9% of AML patients harbor a mutation in the ITD in various subtypes. The frequency of ITD mutations was 4% in ALL. Various insertions of nucleotides in ITD were observed, similar to those described in the literature previously. CONCLUSION: These preliminary data suggest that flt3-ITD mutations may play an important role in leukemogenesis in a proportion of children, particularly in the case of AML.</Abstract>
  </Article>
</ArticleSet>